Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Mice with too much Claudin-6 have skin barrier problems and abnormal hair growth.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

CCL5 is important for the hair growth potential of human dermal papilla cells.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Controlling Tslp can improve health in AEC syndrome patients.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Sintilimab treatment caused hair loss but led to complete tumor remission.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

CMV infection increases the risk of GvHD after bone marrow transplants.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Entospletinib effectively prevents eye and skin GVHD in mice.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

XiaoZhenFang (XZF) can help prevent skin problems caused by certain cancer drugs.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Cadd4 effectively reduces cholesterol levels without side effects.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.